Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

April 16, 2019April 16, 2019

Age-related Changes in TTR Gene Expression May Explain Disease Differences Within Families, Study Suggests

News

Variability in the onset and penetrance of TTR-related amyloidosis (ATTR) among members of the same family may be linked to the expression of different copies of the TTR gene ... Read more

February 19, 2019February 19, 2019

FAP More Diverse Than Previously Believed, Review Study Contends

News

A review of 542 cases of hereditary transthyretin amyloid polyneuropathy (ATTR-PN) from more than 100 countries suggests that the clinical symptoms and geographical occurrence of the disease is more ... Read more

January 22, 2019January 22, 2019

Heart Problems Are Top Cause of Death for FAP Patients Who Had Liver Transplant, Study Says

News

Cardiac problems are the leading cause of death among transthyretin familial amyloid polyneuropathy (ATTR, also called FAP) patients who have had a liver transplant, according to a retrospective longitudinal ... Read more

January 8, 2019January 8, 2019

Vyndaqel May Help Halt Neurological Disease Progression in Patients With Val30Met Mutation, Study Reveals

News

Early diagnosis and prompt treatment with Vyndaqel (tafamidis) may help halt neurological disease progression in familial amyloid polyneuropathy (FAP) patients who are positive for the Val30Met mutation, clinical analyses of ... Read more

September 20, 2018September 20, 2018

News

Tests used to assess sensitivity to heat and cold may help diagnose patients with familial amyloid polyneuropathy (FAP) earlier as well as track their improvement after liver transplant, a ... Read more

September 4, 2018September 4, 2018

Portugal Has Highest Prevalence of TTR-FAP, but Rate of New Cases Decreasing, Study Finds

News

Portugal has the highest prevalence of transthyretin familial amyloid polyneuropathy (TTR-FAP) to date, although the number of new cases is decreasing, data from a national epidemiological study shows. Cases ... Read more

August 23, 2018August 23, 2018

Sudoscan and Neuropad Can Detect Disease Severity in FAP Patients, Study Suggests

News

Sudoscan and Neuropad, tests that assess sweat gland function, are effective at diagnosing familial amyloid polyneuropathy (FAP) and assessing small nerve fiber damage, according to researchers. Their study, “Assessment ... Read more

August 2, 2018August 2, 2018

Management of FAP Patients Needs to Include Family Therapy, Researchers Say

News

The hereditary nature of familial amyloid polyneuropathy (FAP), along with the severity and unpredictability of the disease, highlights the risk for great psychological stress among FAP patients and their family ... Read more

July 31, 2018July 31, 2018

Vyndaqel May Ease CNS and Eye Manifestions in Certain FAP Patients, Study Suggests

News

Treatment with 20 mg a day of oral Vyndaqel (tafamidis) is enough for the therapy to reach the central nervous system (CNS) and eyes of familial amyloid polyneuropathy (FAP) ... Read more

July 11, 2018July 11, 2018

Phase 3 Trial Results Supporting Benefits of Patisiran in FAP Published in NEJM

News

A Phase 3 trial testing patisiran as a therapy for hereditary ATTR amyloidosis with polyneuropathy (also called familial amyloid polyneuropathy, or FAP), showed treatment with patisiran safely improved many ... Read more

Pin It on Pinterest